naveen kango

Dr. naveen kango

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Food Chemistry
Verified
Journal Article
Closed access
UJUttam Kumar Jana
Uttam Kumar Jana
RSRahul Kumar Suryawanshi
Rahul Kumar Suryawanshi
BPBhanu Pratap Prajapati
Bhanu Pratap Prajapati
NKnaveen kango
naveen kango

26 July 2011 in Food Biotechnology
Verified
Journal Article
Closed access
NKnaveen kango
naveen kango
SJSumat Chand Jain
Sumat Chand Jain
Microbial inulinases find application in enzymatic hydrolysis of inulin for production of fructose (sweetener) and inulooligosaccharides (prebiotics). Inulin is one of the most abundant nonstructural polysaccharides found widely dispersed in plants and awaits judicious utilization. Demands for an alternative healthy sweetener and multifunctional fructooligosaccharides have prompted investigators to explore microorganisms for inulinase production and to develop bioprocesses for production of high-fructose syrup and oligosaccharides based on enzymatic hydrolysis of raw inulin. Inulinases have been characterized in several molds, yeasts and a few bacteria. Recently, there has been a spurt of interest in finding novel inulinase producers, cloning and expression of inulinase gene in heterologous hosts and use of crude plant inulin and agro-industrial media in both submerged and solid state fermentation for inulinase production. The review discusses current knowledge on production, properties and applications of microbial inulinases and looks into the recent advances in the field.

1 February 2018 in Bioresource Technology
Verified
Journal Article
Closed access
BPBhanu Pratap Prajapati
Bhanu Pratap Prajapati
RSRahul Kumar Suryawanshi
Rahul Kumar Suryawanshi
SASarika Agrawal
Sarika Agrawal
MGManasi Hindu Ghosh
Manasi Hindu Ghosh
NKnaveen kango
naveen kango

1 April 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
UJUttam Kumar Jana
Uttam Kumar Jana
NKnaveen kango
naveen kango

27 July 2021 in Frontiers in Nutrition
Verified
Journal Article
Open access
UJUttam Kumar Jana
Uttam Kumar Jana
NKnaveen kango
naveen kango
Brett PletschkeBrett Pletschke
Brett Pletschke
The gut microbiota in the human body is an important component that plays a pivotal role in the ability of the host to prevent diseases and recover from these diseases. If the human microbiome changes for any reason, it affects the overall functioning of the host. Healthy and vigorous gut microbiota require dietary fiber supplementation. Recently, oligosaccharides have been found to play a significant role in the modulation of microbiota. Several such oligosaccharides, i.e., xylooligosaccharides (XOS), mannooligosaccharides (MOS), and arabino-xylooligosaccharides (AXOS), are derived from hemicellulosic macromolecules such as xylan, mannan, and arabino-xylan, respectively. These oligosaccharides serve as substrates for the probiotic production of health-promoting substances (short-chain fatty acids, branched chain amino acids etc.), which confer a variety of health benefits, including the prevention of some dreaded diseases. Among hemicellulose-derived oligosaccharides (HDOs), XOS have been largely explored, whereas, studies on MOS and AXOS are currently underway. HDOs, upon ingestion, help reduce morbidities by lowering populations of harmful or pathogenic bacteria. The ATP-binding cassette (ABC) transporters are mainly utilized for the uptake of oligosaccharides in probiotics. Butyrate generated by the selective fermentation of oligosaccharides, along with other short-chain fatty acids, reduces gut inflammation. Overall, oligosaccharides derived from hemicelluloses show a similar potential as conventional prebiotics and can be supplemented as functional foods. This review summarizes the role of HDOs in the alleviation of autoimmune diseases (inflammatory bowel disease, Crohn's disease), diabetes, urinary tract infection, cardiovascular diseases, and antimicrobial resistance (AMR) through the modulation of the gut microbiota. The mechanism of oligosaccharide utilization and disease mitigation is also explained.

1 November 2018 in Bioresource Technology
Verified
Journal Article
Closed access
UJUttam Kumar Jana
Uttam Kumar Jana
RSRahul Kumar Suryawanshi
Rahul Kumar Suryawanshi
BPBhanu Pratap Prajapati
Bhanu Pratap Prajapati
HSHemant Soni
Hemant Soni
NKnaveen kango
naveen kango